Medical Science
| Open Access |
DOI: Hematological Parameters in Children and Adolescents with Post-Covid-19 Infection and Juvenile Rheumatoid Arthritis
Norbibi Yadgarova , Tashkent State Medical University, UzbekistanAbstract
The COVID-19 coronavirus pandemic has had a significant impact on the health of children and adolescents, especially those with chronic inflammatory autoimmune diseases. One of the most challenging clinical challenges in recent years has been monitoring patients with juvenile rheumatoid arthritis who have recovered from COVID-19.
Keywords
Post-COVID-19 syndrome, autoimmune diseases, rheumatology
References
Abdullaeva D.A. Pediatric rheumatology. – Tashkent: Medicine, 2021.
Nasyrov Kh.N., Karimova M.M. Post-Covid syndrome in children. – Tashkent, 2023.
Belyaeva E.A. Hematological changes in COVID-19 in children // Pediatrics. – 2022. – No. 4. – P. 15–22.
Smirnov A.V. Juvenile rheumatoid arthritis in children and adolescents. – Moscow, 2020.
Ismailov Zh.R. Features of the course of COVID-19 in children with chronic diseases // Medical Journal of Uzbekistan. – 2023. – No. 2. – pp. 41–47.
World Health Organization. Coronavirus disease (COVID-19) pandemic reports. – Geneva, 2021–2024.
Cassidy J.T., Petty R.E. Textbook of Pediatric Rheumatology. – Philadelphia, 2021.
Feldstein L.R. Multisystem inflammatory syndrome in children associated with COVID-19 // New England Journal of Medicine. – 2020. – Vol. 383. – P. 334–346.
Ganieva N.S. Anemic syndrome in children with rheumatoid arthritis // Pediatrics vabolalarkhirurgiyasi. – 2022. – No. 1. – pp. 55–61.
Ministry of Health of the Republic of Uzbekistan. Statistical collection of childhood morbidity. – Tashkent, 2024.
Yuldasheva M.A. Immunological disorders in children after COVID-19. – Samarkand, 2023.
McIntosh K. COVID-19 in children and adolescents // UpToDate. – 2024.
Ravelli A., Martini A. Juvenile idiopathic arthritis // Lancet. – 2021. – Vol. 398. – P. 767–778.
Rakhmatova Sh.B. Hematological parameters in adolescents with chronic inflammatory diseases // Bulletin of TMA. – 2022. – No. 3. – pp. 27–34.
Download and View Statistics
Copyright License
Copyright (c) 2026 Norbibi Yadgarova
This work is licensed under a Creative Commons Attribution 4.0 International License.
Authors retain the copyright of their manuscripts, and all Open Access articles are disseminated under the terms of the Creative Commons Attribution License 4.0 (CC-BY), which licenses unrestricted use, distribution, and reproduction in any medium, provided that the original work is appropriately cited. The use of general descriptive names, trade names, trademarks, and so forth in this publication, even if not specifically identified, does not imply that these names are not protected by the relevant laws and regulations.